Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. (TCRT) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 19 transactions totaling $1.3M, demonstrating a bullish sentiment with $1.3M in net insider flow. The most recent transaction on Nov 21, 2025 involved a transaction of 4,183 shares valued at $13.2K.
TCRT Insider Activity Summary
Who Is Buying TCRT Stock?
No significant insider buying has been recorded for TCRT in the recent period.
Who Is Selling TCRT Stock?
No significant insider selling has been recorded for TCRT in the recent period.
Is Alaunos Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TCRT is bullish with an Insider Alignment Score of 99/100 and a net flow of $1.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TCRT Frequently Asked Questions
Understanding TCRT Insider Activity
Insider trading at Alaunos Therapeutics, Inc. (TCRT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading TCRT stock, having executed 19 transactions in the past 90 days. The most active insider is Jaime Vieser (Executive), who has made 4 transactions totaling $829.4K.
Related Tools
Track Alaunos Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TCRT file new Form 4 transactions